SFV785: A Kinase Inhibitor That Disrupts Dengue Virus Assembly
Author Information
Author(s): Anwar Azlinda, Hosoya Takamitsu, Leong Kok Mun, Onogi Hiroshi, Okuno Yukiko, Hiramatsu Toshiyuki, Koyama Hiroko, Suzuki Masaaki, Hagiwara Masatoshi, Garcia-Blanco Mariano A.
Primary Institution: Duke-NUS Graduate Medical School, Singapore
Hypothesis
Can SFV785 inhibit dengue virus propagation by targeting host kinases?
Conclusion
SFV785 inhibits dengue virus assembly by altering the distribution of the envelope protein without affecting viral RNA synthesis.
Supporting Evidence
- SFV785 did not inhibit viral RNA synthesis or translation.
- Electron microscopy revealed abnormal viral particles lacking nucleocapsids in SFV785-treated cells.
- SFV785 altered the distribution of the dengue virus envelope protein away from the replication complex.
Takeaway
SFV785 is a special medicine that helps stop the dengue virus from making more copies of itself by messing up how the virus puts itself together.
Methodology
The study involved testing the effects of SFV785 on dengue virus-infected cells, analyzing viral protein and RNA levels, and using electron microscopy to observe viral particle morphology.
Potential Biases
Potential conflicts of interest due to authors' ownership stakes in KinoPharma.
Limitations
The study does not explore the long-term effects of SFV785 or its efficacy in vivo beyond preliminary toxicity data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website